VOQUEZNA DUAL PAK

Phathom Pharmaceuticals Inc.🇺🇸 United States

FDA Page

Effective Date: Jul 16, 2026
Approval ID: 0cb2ee04-8581-46c8-a781-7be170ab5c86
Products: 2 registered
Version: 17

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK safely and effectively. See full prescribing information for VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK. VOQUEZNA TRIPLE PAK (vonoprazan tablets; amoxicillin capsules; clarithromycin tablets), co-packaged for oral use VOQUEZNA DUAL PAK (vonoprazan tablets; amoxicillin capsules) co-packaged for oral use Initial U.S. Approval: 2022

Quick Stats

Total Products2

Labelers2

Label Sections36

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.